HK285A - 3-methyleneazetidine derivatives - Google Patents

3-methyleneazetidine derivatives

Info

Publication number
HK285A
HK285A HK2/85A HK285A HK285A HK 285 A HK285 A HK 285A HK 2/85 A HK2/85 A HK 2/85A HK 285 A HK285 A HK 285A HK 285 A HK285 A HK 285A
Authority
HK
Hong Kong
Prior art keywords
methyleneazetidine
derivatives
methyleneazetidine derivatives
Prior art date
Application number
HK2/85A
Other languages
English (en)
Inventor
Herndon Jenkins
Albert Duncan Cale
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of HK285A publication Critical patent/HK285A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK2/85A 1979-07-19 1985-01-03 3-methyleneazetidine derivatives HK285A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/059,093 US4260606A (en) 1979-07-19 1979-07-19 3-Methyleneazetidine derivatives

Publications (1)

Publication Number Publication Date
HK285A true HK285A (en) 1985-01-11

Family

ID=22020806

Family Applications (1)

Application Number Title Priority Date Filing Date
HK2/85A HK285A (en) 1979-07-19 1985-01-03 3-methyleneazetidine derivatives

Country Status (19)

Country Link
US (1) US4260606A (en:Method)
JP (1) JPS5625152A (en:Method)
AU (1) AU538139B2 (en:Method)
BE (1) BE884356A (en:Method)
CH (1) CH647233A5 (en:Method)
DE (1) DE3027169A1 (en:Method)
ES (1) ES8106492A1 (en:Method)
FR (1) FR2461699A1 (en:Method)
GB (1) GB2055818B (en:Method)
HK (1) HK285A (en:Method)
HU (1) HU184806B (en:Method)
IE (1) IE50015B1 (en:Method)
IL (1) IL60376A (en:Method)
IT (1) IT1141608B (en:Method)
NL (1) NL8004163A (en:Method)
PT (1) PT71582A (en:Method)
SE (1) SE448994B (en:Method)
SG (1) SG26184G (en:Method)
ZA (1) ZA803777B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540690A (en) * 1982-02-09 1985-09-10 The Upjohn Company 2-(Phenylmethylene)cycloalkylamines and -azetidines
US4652559A (en) * 1982-08-16 1987-03-24 The Upjohn Company 2-(Phenylmethylene)cycloalkyl-azetidines
JPS6086358U (ja) * 1983-11-21 1985-06-14 積水化成品工業株式会社 柔道用マツト
DE4445322A1 (de) * 1994-12-19 1996-06-20 Trw Repa Gmbh Kraftbegrenzer für Fahrzeug-Sicherheitsgurtsysteme
FR2783246B1 (fr) * 1998-09-11 2000-11-17 Aventis Pharma Sa Derives d'azetidine, leur preparation et les medicaments les contenant
KR100652994B1 (ko) 1998-09-11 2006-11-30 아방티 파르마 소시에테 아노님 아제티딘 유도체, 이의 제조방법 및 이를 함유하는 약제
US6479479B2 (en) * 2000-03-03 2002-11-12 Aventis Pharma S.A. Azetidine derivatives, their preparation and pharmaceutical compositions containing them
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
EP2424539A4 (en) * 2009-04-30 2012-09-19 Supernus Pharmaceuticals Inc PROCESS FOR TREATING DEPRESSION
CA2864088C (en) 2012-02-08 2020-04-28 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481920A (en) * 1965-10-22 1969-12-02 Lilly Co Eli Azetidinones
US3458635A (en) * 1966-08-08 1969-07-29 Robins Co Inc A H Compositions containing 3-di-substituted methylene pyrrolidines and methods of treating depression
US3494964A (en) * 1969-01-13 1970-02-10 Lilly Co Eli Alpha-halo-alpha-amino ketones
US3732247A (en) * 1970-08-14 1973-05-08 Robins Co Inc A H 3-di-substituted methylene pyrrolidines wherein the 1-or n-lower-alkyl substituent contains at least two carbon atoms
US4002766A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated Antiarrhythmia methods
US4078072A (en) * 1975-01-24 1978-03-07 Carlo Erba S.P.A. N-tricyclic derivatives of azetidine and pharmaceutical compositions and methods containing them
US4118499A (en) * 1975-10-15 1978-10-03 Glaxo Laboratories Limited Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes
US4065573A (en) * 1976-06-03 1977-12-27 The Upjohn Company 4-Amino-4-phenylcyclohexanone ketal compositions and process of use
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods

Also Published As

Publication number Publication date
FR2461699B1 (en:Method) 1983-04-22
HU184806B (en) 1984-10-29
ES493499A0 (es) 1981-07-01
BE884356A (fr) 1980-11-17
JPS6328906B2 (en:Method) 1988-06-10
NL8004163A (nl) 1981-01-21
ES8106492A1 (es) 1981-07-01
PT71582A (en) 1980-08-01
IE801487L (en) 1981-01-19
IL60376A0 (en) 1980-09-16
IT1141608B (it) 1986-10-01
GB2055818B (en) 1983-06-22
SE8005236L (sv) 1981-01-20
AU6061880A (en) 1981-01-22
CH647233A5 (fr) 1985-01-15
IL60376A (en) 1983-07-31
IE50015B1 (en) 1986-01-22
IT8068155A0 (it) 1980-07-18
US4260606A (en) 1981-04-07
AU538139B2 (en) 1984-08-02
SG26184G (en) 1985-03-29
ZA803777B (en) 1981-09-30
GB2055818A (en) 1981-03-11
SE448994B (sv) 1987-03-30
FR2461699A1 (fr) 1981-02-06
JPS5625152A (en) 1981-03-10
DE3027169A1 (de) 1981-02-19

Similar Documents

Publication Publication Date Title
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
NZ193800A (en) 3-vinylcephalosporin derivatives
NZ193799A (en) 3-vinyl-cephalosporin derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
CU35300A (en) Pyrrholidine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
GB2053899B (en) Terahydrophthalamide derivatives
MY8400201A (en) Isopropylamino-pyrimidine derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
PH15098A (en) 15-sulfonamidoprostaglandin derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
GB2065110B (en) Decaprenylamine derivatives
GB2042508B (en) 3-alkoxy-penem derivatives
GB2065109B (en) Decaprenylamine derivatives
GB2122601B (en) Tetrahydronaphthacene derivatives
GB2055374B (en) -amino-3 nor-tropane derivatives
GB2060606B (en) Propionamidoxime derivatives